Adalimumab, Anakinra, and Tocilizumab in Patients With Noninfectious Uveitis: A Multicenter Randomized Controlled Trial
David Saadoun, Amine Ghembaza, Sarah Touhami, Nicolas Girszyn et autres
fr, ae, us (code pays fourni par la source)
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
David Saadoun, Amine Ghembaza, Sarah Touhami, Nicolas Girszyn et autres
fr, ae, us (code pays fourni par la source)
P. Mercié, Visal Keo, A. Contis, Étienne Rivière et autres
fr (code pays fourni par la source)
Leire Etchandy, Marie-Noëlle Méaux, Olivier Richer, Skander Korbi et autres
BACKGROUND: Non-infectious paediatric granulomatous uveitis (PGU) is a rare disease that is idiopathic in more than half of affected children. The diagnosis of definite ocular sarcoidosis (OS) must be supported by the presence of non-caseating granulomas detected in biopsy, and is therefore …
fr (code pays fourni par la source)
Étienne Rivière, Valentine Horiot, Ghoufrane Tlili, Charles Mesguich et autres
Etienne Rivière, Valentine Horiot, Ghoufrane Tlili, Charles Mesguich, Fanny Bletzung, Félix Blaison, Claire Tinevez, Carine Greib, Emmanuel Ribeiro, Estiba
fr (code pays fourni par la source)
David Saadoun, Georgina Maalouf, Matheus Henrique Vieira, S. Trad et autres
BACKGROUND: Cyclophosphamide and infliximab are recommended as induction therapies for severe Behçet's syndrome. Whether infliximab is safer and more effective than cyclophosphamide in treating severe Behçet's syndrome is not known. METHODS: intravenously at weeks 0, 4, 8, 12, 16, and 20, with …
fr, lu, us (code pays fourni par la source)
Victor Hémar, Stéphane Bouchet, Emmanuel Ribeiro, Perrine Prier et autres
Lenacapavir, a pioneering HIV capsid inhibitor approved for HIV treatment, is used in conjunction with other antiretroviral therapies (ARTs) in multidrug-resistant HIV infections and has shown efficacy in treatment-naive patients.1,2 Administered subcutaneously every 6 months, it represents a long-acting treatment option. In …
fr (code pays fourni par la source)
Isabelle Redonnet‐Vernhet, P. Mercié, Louis Lebreton, Jean‐Marc Blouin et autres
Acute hepatic porphyrias are inherited metabolic disorders of heme biosynthesis characterized by the accumulation of toxic intermediate metabolites responsible for disabling acute neurovisceral attacks. Givosiran is a newly approved siRNA-based treatment of acute hepatic porphyria targeting the first and rate-limiting δ-aminolevulinic acid …
fr (code pays fourni par la source)
Étienne Rivière, Wendy Jourde, Noémie Gensous, Xavier Demant et autres
BACKGROUND: Infliximab is currently recommended as a third-line treatment for refractory sarcoidosis. Data in function of clinical phenotype are currently lacking. We evaluated patients' characteristics and responses to infliximab according to their GenPhenReSa cluster. METHODS: We evaluated clinical and biological characteristics of …
fr (code pays fourni par la source)
Clémence Than Trong, Diane Levesque, Marie‐Bénédicte Rougier, Emmanuel Ribeiro et autres
fr (code pays fourni par la source)
Guillaume Vial, Laure Barthod, Sophie C. Schneider, P. Mercié et autres
Chronic active Epstein-Barr virus (CAEBV) infection is usually a fatal disease associated with clonal proliferation of EBV-infected T or NK cells. We present the case of a 33-year-old Peruvian patient who developed a multisystem CAEBV, notably responsible for exceptional ophthalmological and renal …
fr (code pays fourni par la source)
Antoine Soulages, Thierry Maisonobe, Pascal Auzou, A. Petit et autres
fr (code pays fourni par la source)
Chris Wymant, Daniela Bezemer, François Blanquart, Luca Ferretti et autres
increase (i.e., a ~3.5-fold to 5.5-fold increase) in viral load compared with, and exhibited CD4 cell decline twice as fast as, 6604 individuals with other subtype-B strains. Without treatment, advanced HIV-CD4 cell counts below 350 cells per cubic millimeter, with long-term clinical …
gb, nl, fr, se, de, ch, us, fi (code pays fourni par la source)
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic